Failure to detect genetic alteration of the mannose-6- phosphate/insulin-like growth factor 2 receptor (M6P/IGF2R) gene in hepatocellular carcinomas in Japan

Hepatology

Volumn 29, Issue 6, 1999, Pages 1718-1721

  Wada, I ^a   Kanada, H ^a   Nomura, K ^a   Kato, Y ^a   Machinami, R ^a   Kitagawa, T ^a  

^a CANCER INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

SOMATOMEDIN B RECEPTOR;

ARTICLE; GENE INACTIVATION; GENE MUTATION; HUMAN; HUMAN TISSUE; JAPAN; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; PRIORITY JOURNAL;

EID: 0032991094     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510290635     Document Type: Article

References (22)

1. 1 Kornfeld S. Structure and function of the mannose 6‐phosphate/insulin like growth factor II receptors. Ann Rev Biochem 1992 ; 61: 307–330. MEDLINE
2. 2 Cohick WS, Clemmons DR. The insulin‐like growth factors. Ann Rev Physiol 1993 ; 55: 131–153.
3. 3 De Souza AT, Yamada T, Mills JJ, Jirtle RL. Imprinted genes in liver carcinogenesis. Faseb J 1997 ; 11: 60–67. MEDLINE
4. 4 Jirtle RL, Hankins GR, Reisenbichler H, Boyer IJ. Regulation of mannose 6‐phosphate/insulin‐like growth factor‐II receptors and transforming growth factor beta during liver tumor promotion with phenobarbital. Carcinogenesis 1994 ; 15: 1473–1478. MEDLINE
5. 5 Yamada T, De Souza AT, Finkelstein S, Jirtle RL. Loss of the gene encoding mannose 6‐phosphate/insulin‐like growth factor II receptor is an early event in liver carcinogenesis. Proc Natl Acad Sci U S A 1997 ; 94: 10351–10355. MEDLINE
6. 6 De Souza AT, Hankins GR, Washington MK, Fine RL, Orton TC, Jirtle RL. Frequent loss of heterozygosity on 6q at the mannose 6‐phosphate/insulin‐like growth factor II receptor locus in human hepatocellular tumors. Oncogene 1995 ; 10: 1725–1729. MEDLINE
7. 7 Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, Mitani T, et al. Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma. J Gastroent Hepatol 1995 ; 10: 179–185.
8. 8 Nishida N, Fukuda Y, Kokuryu H, Sadamoto T, Isowa G, Honda K, Yamaoka Y, et al. Accumulation of allelic loss on arms of chromosomes 13q, 16q and 17p in the advanced stages of human hepatocellular carcinoma. Int J Cancer 1992 ; 51: 862–868. MEDLINE
9. 9 Ashida K, Kishimoto Y, Nakamoto K, Wada K, Shiota G, Hirooka Y, Kamisaki Y, et al. Loss of heterozygosity of the retinoblastoma gene in liver cirrhosis accompanying hepatocellular carcinoma. J Cancer Res Clin Oncol 1997 ; 123: 489–495. MEDLINE
10. 10 Orita M, Iwahara H, Kanazawa H, Hayashi K, Sekiya T. Detection of polymorphism of human DNA by gel electrophoresis as single‐strand conformation polymorphism. Proc Natl Acad Sci U S A 1989 ; 86: 2766–2770. MEDLINE
11. 11 De Souza AT, Hankins GR, Washington MK, Orton TC, Jirtle RL. M6P/IGF2R gene is mutated in human hepatocellular carcinomas with loss of heterozygosity. Nat Genet 1995 ; 11: 447–449. MEDLINE
12. 12 Myrnes B, Giercksky KE, Krokan H. Interindividual variation in the activity of O6‐methyl guanine‐DNA methyltransferase and uracil‐DNA glycosylase in human organs. Carcinogenesis 1983 ; 4: 1565–1568. MEDLINE
13. 13 Imai Y, Oda H, Nakatsuru Y, Ishikawa T. A polymorphism at codon 160 of human O6‐methylguanine‐DNA methyltransferase gene in young patients with adult type cancers and functional assay. Carcinogenesis 1995 ; 16: 2441–2445. MEDLINE
14. 14 Edara S, Kanugula S, Goodtzova K, Pegg AE. Resistance of the human O6‐alkylguanine‐DNA alkyltransferase containing arginine at codon 160 to inactivation by O6‐benzylguanine. Cancer Res 1996 ; 56: 5571–5575. MEDLINE
15. 15 Storey A, Thomas M, Kalita A, Harwood C, Gardiol D, Mantovani F, Breuer J, et al. Role of a p53 polymorphism in the development of human papilloma‐virus‐associated cancer. Nature 1998 ; 393: 229–234. MEDLINE
16. 16 Simonetti RG, Camma F, Fiorello F, Politti F, D'Amico G, Pagliaro L. Hepatocellular carcinoma: a worldwide problem and the major risk factors. Dig Dis Sci 1991 ; 36: 962–972. MEDLINE
17. 17 Yoshioka K. Detection of hepatitis C virus by polymerase chain reaction and response to interferon‐therapy: relationship to genotypes of hepatitis C virus. Hepatology 1992 ; 16: 293–299. MEDLINE
18. 18 Ozturk M. p53 mutation in hepatocellular carcinoma after aflatoxin exposure. Lancet 1991 ; 338: 1356–1359. MEDLINE
19. 19 Bressac B, Kew M, Wands J, Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 1991 ; 350: 429–431. MEDLINE
20. 20 Goto J, Figlewicz DA, Marineau C, Khodr N, Rouleau GA. Dinucleotide repeat polymorphism at the IGF2R locus. Nucleic Acids Res 1992 ; 20: 923. MEDLINE
21. 21 Hol FA, Geurds MPA, Hamel BCJ, Mariman ECM. Improving the polymorphism content of the 3′ UTR of the human IGF2R gene. Hum Mol Genet 1992 ; 1: 347. MEDLINE
22. 22 Piao Z, Choi Y, Park C, Lee WJ, Park JH, Kim H. Deletion of the M6P/IGF2r gene in primary hepatocellular carcinoma. Cancer Lett 1997 ; 120: 39–43. MEDLINE